Novacea, Inc. (NASDAQ: NOVC) announced today that two of its product candidates, DN-101 and AQ4N, were featured in several oral and poster presentations at the 2006 American Society of Clinical Oncology (ASCO) Annual Meeting held June 2-6 in Atlanta.
